Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
- PMID: 27269061
- DOI: 10.1016/j.vaccine.2016.05.046
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
Abstract
mRNA represents a new platform for the development of therapeutic and prophylactic vaccines with high flexibility with respect to production and application. We have previously shown that our two component self-adjuvanted mRNA-based vaccines (termed RNActive® vaccines) induce balanced immune responses comprising both humoral and cellular effector as well as memory responses. Here, we evaluated the early events upon intradermal application to gain more detailed insights into the underlying mode of action of our mRNA-based vaccine. We showed that the vaccine is taken up in the skin by both non-leukocytic and leukocytic cells, the latter being mostly represented by antigen presenting cells (APCs). mRNA was then transported to the draining lymph nodes (dLNs) by migratory dendritic cells. Moreover, the encoded protein was expressed and efficiently presented by APCs within the dLNs as shown by T cell proliferation and immune cell activation, followed by the induction of the adaptive immunity. Importantly, the immunostimulation was limited to the injection site and lymphoid organs as no proinflammatory cytokines were detected in the sera of the immunized mice indicating a favorable safety profile of the mRNA-based vaccines. Notably, a substantial boostability of the immune responses was observed, indicating that mRNA can be used effectively in repetitive immunization schedules. The evaluation of the immunostimulation following prime and boost vaccination revealed no signs of exhaustion as demonstrated by comparable levels of cytokine production at the injection site and immune cell activation within dLNs. In summary, our data provide mechanistic insight into the mode of action and a rational for the use of mRNA-based vaccines as a promising immunization platform.
Keywords: Antigen-presenting cells; Boostability; Immunostimulation; Innate immunity; mRNA vaccine.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Routing dependent immune responses after experimental R848-adjuvated vaccination.Vaccine. 2018 Mar 7;36(11):1405-1413. doi: 10.1016/j.vaccine.2018.01.077. Vaccine. 2018. PMID: 29409680
-
Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.J Immunother. 2011 Jan;34(1):1-15. doi: 10.1097/CJI.0b013e3181f7dbe8. J Immunother. 2011. PMID: 21150709
-
Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.J Immunol. 2014 Aug 15;193(4):1920-30. doi: 10.4049/jimmunol.1400948. Epub 2014 Jul 14. J Immunol. 2014. PMID: 25024381
-
Skin delivery of a hybrid liposome/ISCOM vaccine implicates a role for adjuvants in rapid modulation of inflammatory cells involved in innate immunity before the enhancement of adaptive immune responses.Immunol Cell Biol. 1998 Jun;76(3):245-55. doi: 10.1046/j.1440-1711.1998.00742.x. Immunol Cell Biol. 1998. PMID: 9682968 Review.
-
An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity.Vaccine. 2016 Nov 11;34(47):5815-5818. doi: 10.1016/j.vaccine.2016.08.051. Epub 2016 Oct 13. Vaccine. 2016. PMID: 27745952 Review.
Cited by
-
Making the Next Generation of Therapeutics: mRNA Meets Synthetic Biology.ACS Synth Biol. 2023 Sep 15;12(9):2505-2515. doi: 10.1021/acssynbio.3c00253. Epub 2023 Sep 6. ACS Synth Biol. 2023. PMID: 37672348 Free PMC article. Review.
-
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.Mol Ther. 2019 Apr 10;27(4):710-728. doi: 10.1016/j.ymthe.2019.02.012. Epub 2019 Feb 19. Mol Ther. 2019. PMID: 30846391 Free PMC article. Review.
-
New Vaccine Technologies to Combat Outbreak Situations.Front Immunol. 2018 Sep 19;9:1963. doi: 10.3389/fimmu.2018.01963. eCollection 2018. Front Immunol. 2018. PMID: 30283434 Free PMC article. Review.
-
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.Antibodies (Basel). 2024 Feb 8;13(1):13. doi: 10.3390/antib13010013. Antibodies (Basel). 2024. PMID: 38390874 Free PMC article. Review.
-
Advances in mRNA Vaccines for Infectious Diseases.Front Immunol. 2019 Mar 27;10:594. doi: 10.3389/fimmu.2019.00594. eCollection 2019. Front Immunol. 2019. PMID: 30972078 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous